A study analysing medication-induced Weight Loss as a addition to a multidisciplinary lifestyle weight management program in the setting of VA healthcare system
Latest Information Update: 22 Dec 2020
At a glance
- Drugs Liraglutide (Primary) ; Naltrexone/bupropion (Primary) ; Orlistat (Primary) ; Phentermine/topiramate (Primary)
- Indications Obesity
- Focus Adverse reactions; Therapeutic Use
- 22 Dec 2020 New trial record
- 06 Nov 2020 Results presented at The Obesity Society Annual Meeting Scientific Sessions 2020